Category: Editors’ Pick

Don’t Assume A 14-Day Quarantine Is Enough To Prevent Covid-19 Spread

A minority of Covid-19 cases have an incubation period longer than two weeks, and the Chinese government has started retooling its policies accordingly.

Why Are Covid-19 Cases Increasing? Here Are 7 Reasons

Friday had over 194,000 new reported cases in the U.S. and over 82,000 people hospitalized due to Covid-19.

AstraZeneca-Oxford Vaccine Up To 90% Effective At Preventing Covid-19, Early Results Show

The vaccine is cheaper and much easier to transport than Pfizer and Moderna’s vaccines, which are 95% effective.

Covid-19 Patients Are ‘Highly Infectious’ Within Five Days Of Showing Symptoms, Study Shows, Explaining Pandemic’s Rapid Spread

Research indicates that the virus is “short-lived” and that patients are no longer infectious after nine days of showing symptoms.

Pfizer, BioNTech To Seek Emergency Approval For Covid-19 Vaccine On Friday

Clinical trials show the vaccine to be 95% effective at preventing Covid-19.

Repercussions Of The Covid Crisis: A Conversation With Michael Milken

You’ll find this conversation with Mike Milken, who has done tremendously effective work in combating such diseases as cancer and now Covid-19, extremely timely, instructive—and hopeful.

World Health Organization Rejects Remdesivir, The Antiviral Trump Took For Covid-19, Saying There’s No Evidence It Helps Recovery Or Survival

Remdesivir is one of the only drugs approved by the Food and Drug Administration to treat Covid-19.

Denmark Says Mutant Covid-19 Strain From Mink Is ‘Most Likely’ Extinct

After more than 200 people caught mink-related Covid-19, the country ordered the culling of its entire 17-million-strong herd of mink.

Tyson Foods Managers Placed Bets On How Many Workers Would Catch Covid-19, Wrongful Death Lawsuit Alleges

The lawsuit alleges Tyson displayed a “wilful and wanton disregard for worker safety” in a plant where over 1,000 employees caught Covid-19.

Oxford Vaccine Induces ‘Robust’ Immune Response In Older Adults, Early Findings Show

Older adults, who are most at risk from the coronavirus, usually respond less well to vaccines.